Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XELOX plus gemcitabine in irinotecan pre-treated advanced colorectal cancer
NCT00496704Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Jan 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in colorectal cancer (CRC), sponsored by Yonsei University. Status: unknown.
02
Drugs
gemcitabine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00496704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00496704.